Steve Harr - 06 Mar 2026 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
President & CEO, Director
Signature
/s/ Aaron M. Grossman, Attorney-in-Fact for Steve Harr
Issuer symbol
SANA
Transactions as of
06 Mar 2026
Net transactions value
$0
Form type
4
Filing time
10 Mar 2026, 16:16:12 UTC
Previous filing
06 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Harr Steve President & CEO, Director C/O SANA BIOTECHNOLOGY, INC., 188 EAST BLAINE STREET, SUITE 350, SEATTLE /s/ Aaron M. Grossman, Attorney-in-Fact for Steve Harr 10 Mar 2026 0001627387

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SANA Common Stock Options Exercise +41,666 +0.53% $0.000000* 7,918,596 06 Mar 2026 Direct
transaction SANA Common Stock Options Exercise +50,000 +0.63% $0.000000* 7,968,596 07 Mar 2026 Direct
transaction SANA Common Stock Tax liability -11,526 -0.14% $3.13* 7,957,070 09 Mar 2026 Direct
transaction SANA Common Stock Tax liability -12,819 -0.16% $3.10* 7,944,251 09 Mar 2026 Direct
holding SANA Common Stock 682,500 06 Mar 2026 Held by Harr Family Irrevocable Trust of 2015 dtd 12/28/2015
holding SANA Common Stock 167,000 06 Mar 2026 Held by Brian L Harr TTEE CCH Irrevocable Trust U/A DTD 03/25/2021 F1
holding SANA Common Stock 167,000 06 Mar 2026 Held by Brian L Harr TTEE JOH Irrevocable Trust U/A DTD 03/25/2021 F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Restricted Stock Units Options Exercise -41,666 -25% $0.000000* 125,001 06 Mar 2026 Common Stock 41,666 Direct F2, F3
transaction SANA Restricted Stock Units Options Exercise -50,000 -33% $0.000000* 100,000 07 Mar 2026 Common Stock 50,000 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Brian L. Harr is the trustee of these trusts, whose sole beneficiaries are members of the reporting person's immediate family.
F2 Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
F3 The award vested as to 25% of the restricted stock units on March 6, 2026, and the remaining restricted stock units will vest in three equal installments on each of March 6, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
F4 The award vested as to 25% of the restricted stock units on each of March 7, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of March 7, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.